Instability of the HLA-E Peptidome of HIV Presents a Major Barrier to Therapeutic Targeting
Background: Human leukocyte antigen (HLA) class Ia molecules present peptides derived from the ER for recognition by cytotoxic T lymphocytes. As such, HLA class Ia-restricted peptides are well characterised drug targets for infectious diseases. However, their clinical potential is limited by the high polymorphism of the HLA class I genes within the population. In contrast,…